0.056
0.00 (-3.45%)
| Previous Close | 0.058 |
| Open | 0.059 |
| Volume | 1,058,665 |
| Avg. Volume (3M) | 477,837 |
| Market Cap | 30,412,968 |
| Price / Sales | 4.36 |
| Price / Book | 4.99 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Profit Margin | -131.48% |
| Operating Margin (TTM) | -108.18% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | -2.30% |
| Total Debt/Equity (MRQ) | 7.02% |
| Current Ratio (MRQ) | 1.61 |
| Operating Cash Flow (TTM) | -5.58 M |
| Levered Free Cash Flow (TTM) | -2.47 M |
| Return on Assets (TTM) | -48.68% |
| Return on Equity (TTM) | -98.08% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | CTRLBIONIC FPO [CBL] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -3.5 |
| Relative Valuation | NA |
| Financial Health | -2.5 |
| AI Insight | NA |
| Weighted Average | -1.50 |
Select this tab to load the latest available analysis.
|
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 46.41% |
| % Held by Institutions | 21.50% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |